From: DAB2IP predicts treatment response and prognosis of ESCC patients and modulates its radiosensitivity through enhancing IR-induced activation of the ASK1-JNK pathway
Variable
P-values
Hazard ratios (95% CI)
T status
< 0.001
 T2/3
1.000
 T4
2.975 (1.869–4.736)
CRT response
0.004
 CR
 Non-CR
2.528 (1.350–4.735)
DAB2IP expression
 High
 Low
4.056 (1.855–8.867)